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Summary
QUESTIONS UNDER STUDY: To describe a population-
based sample of patients with diabetes and the quality of
their care in the canton of Vaud, Switzerland, as a baseline
measure for the evaluation of the “Programme cantonal Di-
abète”.
METHODS: We conducted a self-administered paper-
based questionnaire survey. Noninstitutionalised adult
(aged ≥18 years) patients with diabetes diagnosed for at
least 1 year and residing in the canton of Vaud were re-
cruited by community pharmacies. Women with gestational
diabetes, people with obvious cognitive impairment or
people not sufficiently fluent in French were excluded.
Primary outcomes were recommended processes-of-care
and outcomes of care (glycosylated haemoglobin [HbA1c],
generic and disease-specific health-related quality of life
(HRQoL), overall care score in relation to the Chronic Care
Model). Other measures included diabetes education, self-
management support and self-efficacy, health status, health
behaviour and demographics.
RESULTS: A total of 519 patients with diabetes were in-
cluded. Whereas the mean HbA1c level was 7.3% (n =
177, 95% confidence interval 7.1–7.5), diabetes-specific
processes-of-care and influenza vaccination were reported
by less than two-thirds of the patients. Physical activity and
diet recommendations results mirrored patients’ difficulties
with their management in daily life and diabetes-specific
HRQoL was worst in the dimensions relative to diet (eat-
ing and drinking) and sex life. A minority of patients repor-
ted ever having participated in diabetes education courses
(32.8%). Overall, patients were satisfied with their care and
the support they received.
CONCLUSIONS: This study provides a broad picture of
the experiences of people living with diabetes in the canton
of Vaud. It shall guide the development of targeted inter-
ventions within the “Programme cantonal Diabète”.
Trial registration number: ClinicalTrials.gov, identifier
NCT01902043.
Key words:diabetes; healthcare quality; cohort study;
questionnaire
Introduction
Worldwide more than 370 million people had diabetes in
2012 [1]. Its occurrence continues to increase, with de-
bilitating clinical consequences [2, 3]. Despite a universal
healthcare system, Switzerland is not protected against this
upward trend. The overall prevalence of diabetes in
Switzerland was reported to be 6.1% in 2010 [4] and 6.6%
in 2006 in the canton of Vaud, Switzerland [5]. However,
only scarce data are available regarding patient character-
istics and the quality of their care [6]. Indeed, previous
Swiss data showed that there was room for improvement
regarding diabetes care and adherence to diabetes
guidelines [7–9]. Although diabetes-specific processes-of-
care were not so often performed by primary care physi-
cians (two-thirds of patients had had annual eye and foot
screening, 50% had had annual renal assessment) [8], this
was somewhat better than initially measured [7].
Population-based studies are essential when studying
chronic diseases, as they can offer an overall understanding
about the trends in the prevalence of diabetes and the state
of diabetes care in specific settings [10]. These studies help
providers and public health advocates better to explain the
current challenges of communities living with diabetes, and
to tailor successfully supportive interventions [11]. In the
past, population-based studies on diabetes had primarily
focused on sociodemographic factors, medical outcomes,
health services and quality-of-care indicators [12–14].
Now, there is a growing interest in using patient-reported
outcome measures [15], with emphasis on patient-reported
health status, health-related quality of life (HRQoL) and
self-management [1, 16]. These latter measures are increas-
ingly important as we now know that patients actively in-
volved in their care are more engaged, better informed and
benefit from improved health outcomes [17]. Indeed, pa-
tients who express higher HRQoL function better within
the healthcare system and perform more health-promoting
activities [18, 19]. Towards this goal, patient-reported out-
comes, in combination with other quality-of-care indicat-
ors, are necessary for healthcare systems to better under-
stand and meet the needs of patients [10].
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In 2010, based on the Chronic Care Model, the Public
Health department of the canton of Vaud created a pioneer
programme in Switzerland, the “Programme cantonal Di-
abète”, to reduce the impact of diabetes on the population,
specifically by (1.) acting on prevention, and (2.) improv-
ing care for people living with diabetes [20]. In this paper,
we aimed to present a comprehensive picture of the health
and care of a population-based sample of patients with dia-
betes. More specifically, we wanted to consider not only
the self-report of usually considered primary processes and
outcomes of care (e.g., HbA1c, HRQoL), but also of other
daily life outcomes of importance to the patients such as
health status, health behaviours, diabetes education, self-
management support and self-efficacy. These data will rep-
resent the baseline measures of CoDiab-VD, a population-
based cohort study on diabetes care in the canton of Vaud,
Switzerland.
Methods
Study population
We conducted a paper-based survey with recruitment in
two waves (autumn of 2011 and summer of 2012). Patients
with diabetes, consecutively recruited through community-
based pharmacies in the canton of Vaud, were invited to
participate if they visited an included pharmacy with a pre-
scription for diabetes-related treatment and/or equipment
(oral antidiabetic medications, insulin, glycaemic strips or
glucose meter). Eligible participants were noninstitutional-
ised adult (aged ≥18 years) patients with a diabetes dia-
gnosis for at least 1 year and residing in that canton. Wo-
men with gestational diabetes, people with obvious cognit-
ive impairment, or people not sufficiently fluent in French
were excluded from the survey. Pharmacists checked pa-
tients’ eligibility and then briefly presented the study; pa-
tients who agreed to receive the questionnaire package
(information letter, questionnaire, prepaid reply envelope)
were asked to complete it at home and to send it back to
the investigators. The total number of eligible participants
and the characteristics of nonparticipating patients were
not recorded by pharmacists because of time and organ-
isation constraints. The recruitment was conducted without
follow-up recall [21]. Sample size was based on estimates
of good precision (i.e., confidence interval width) around
the following primary outcomes: mean glycosylated
haemoglobin (HbA1c), mean Physical and Mental compon-
ent scores (PCS and MCS) of the Short Form-12 Health
Survey (SF-12), Patient Assessment of Chronic Illness
Care (PACIC) global score, and percentage of patients re-
ceiving recommended annual processes-of-care. Given
pharmacy clusters (40 pharmacies, each recruiting 15 pa-
tients, intraclass correlation 0.05, alpha 0.05, beta 0.2), 600
participants were targeted.
The protocol of this study was approved by the Cantonal
Ethics Committee of Research on Human Beings of the
Canton of Vaud (Protocol N° 151/11). Written informed
consent was obtained from all participants, and data were
kept anonymous and confidential.
Data collection
Participants completed a self-administered paper question-
naire. Primary outcomes of interest were recommended
processes and outcomes of care indicators. The processes-
of-care indicators considered were: HbA1c check among
patients who were aware of what HbA1c is (“HbA1c-
aware”), blood pressure measurement, weight measure-
ment, lipid profile, annual diabetic foot examination, an-
nual urine test for microalbuminuria, annual eye examin-
ation by ophthalmologist, seasonal influenza vaccination,
physical activity and diet recommendations. Outcomes of
care were: mean HbA1c among HbA1c-aware patients, gen-
eric and diabetes-specific HRQoL measures (SF-12 PCS
and MCS, score range 0 = worst to 100 = best; Audit of
Diabetes-Dependent Quality of Life 19 – ADDQoL, range
–9 = maximum negative impact of diabetes to +3 = max-
imum positive impact of diabetes), and congruency of care
with the Chronic Care Model (PACIC score, range 1 =
lowest to 5 = highest congruency). We also considered
the following diabetes education, self-management support
and self-efficacy measures: glucose self-monitoring, HbA1c
knowledge, participation in diabetes education course,
membership in the local diabetes association (Association
Vaudoise du Diabète – AVD), knowledge about the “Dia-
betes Passport” (a small booklet, kept by the patient, in
which consultations and medical results are noted),
easiness-difficulty with daily self-management of diabetes
in general, with physical activity, medication and diet, as
well as their level of information about diabetes and source
of information, support and satisfaction with healthcare
team and personal social network. Other data included age,
gender, sociodemographics (relationship status, living situ-
ation, family income in Swiss franc (CHF/month), edu-
cation, employment status, type of residence, nationality),
and diabetes characteristics (type, duration, treatment,
complications), health behaviours (smoking status, alcohol
consumption, physical activity), and comorbidities.
Data analysis
Descriptive analyses were conducted, with data reported as
means or percentages for continuous or categorical vari-
ables, respectively. For primary outcomes, confidence in-
tervals were also calculated, taking into account the hier-
archical structure of the data (clusters of pharmacies). All
analyses were performed using Stata 12.1.
Results
Patients’ characteristics
Out of 1,054 eligible people who accepted a questionnaire
from pharmacists (809 in 2011, 245 in 2012), 519 patients
completed and returned the questionnaire (406 in 2011, 113
in 2012, participation rate of 50.2% and 46.1%, respect-
ively). Table 1 shows participants’ characteristics. The ma-
jority were male (59.7%) and mean age was 64.5 years.
Most reported a diagnosis of type 2 diabetes (66.9%), and
48% of respondents had been diagnosed over 10 years ago.
Although less than 20% of patients reported being current
smokers, almost 50% presented high-risk drinking beha-
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viour, more than 80% were either obese or overweight, and
30% were considered to be inactive physically.
Primary outcomes
Blood pressure, weight, and lipid profile were measured
in over 90% of participants in the prior 12 months (table
2). HbA1c was checked at least once in the last year in
98.3% of HbA1c-aware patients (n = 282). Other processes-
of-care indicators were reported by less than 70% of the pa-
tients. Low percentages were also found for physical activ-
ity and diet recommendations. Among HbA1c-aware pa-
tients, mean patients-reported HbA1c was 7.3% (n = 177).
Whereas generic health-related quality of life results
showed worse physical than mental health (SF-12 PCS:
Table 1: Baseline characteristics of the participants (n = 519 patients with diabetes).
Sociodemographic and general health characteristics
Mean age (SD; range) (n = 519) 64.5 (11.3; 19–91)
Female (n = 519) 40.3%
Marital status (n = 516) Single 8.3%
Married or living with partner 63.8%
Separated, divorced, widowed 27.9%
Education (n = 504) Primary 18.9%
Secondary 56.2%
Tertiary 25.0%
Employment status (n = 503) Employed (full time) 23.7%
Employed (part time) 8.4%
Unemployed or disabled 6.2%
Not in labour force* 61.8%
Quartiles of family income (n = 486) ≤3,499 CHF/month 21.2%
3,500–5,499 CHF/month 26.5%
5,500–9,499 CHF/month 27.8%
≥9,500 CHF/month 17.3%
Unknown 7.2%
Total number of people in household (n = 516) 1 (lived alone) 26.7%
2 55.0%
≥3 18.2%
Place of residence (n = 509) Urban 42.6%
Semiurban 27.5%
Rural 29.9%
Nationality (n = 515) Swiss 88.2%
Other 11.9%
Self-reported health (n = 509) Excellent / very good 14.2%
Good 64.2%
Medium/poor 21.6%
Diabetes
Type of diabetes (n = 519) Type 1 12.7%
Type 2 66.9%
Undetermined 20.4%
Duration of known diabetes (n = 511) ≤10 years 52.1%
>10 years 47.9%
Treatment for diabetes (n = 517) Oral antidiabetic drugs (OAD) 50.7%
Insulin 21.7%
OAD and insulin 27.1%
None/unknown 0.6%
Diabetes-related complication† (n = 505) None 52.5%
1 30.7%
≥2 16.8%
Comorbidity‡ (n = 505) None 17.4%
1 26.9%
≥2 55.6%
Current smoking (n = 509) 17.3%
High-risk drinking§ (n = 484) 48.4%
BMI (n = 481) Overweight (BMI 25–29.9) 35.3%
Obese (BMI ≥30) 46.8%
Physically inactive (n = 494) 29.8%
BMI = body mass index; CHF = Swiss franc; SD = standard deviation
* Not in labour force encompassed retired, annuitant and stay-at-home. † List of diabetes related-complications: myocardial infarction/angina, stroke, retinopathy,
nephropathy, neuropathy, severe hypo- or hyperglycaemia. ‡ List of co-morbidities: heart failure, valvulopathy, hypertension, hyperlipidaemia, chronic respiratory
conditions, peptic ulcer, osteoporosis, osteoarthritis, Parkinson's disease, malignancy, depression, other chronic condition. § High risk drinking: AUDIT-C (Alcohol Use
Disorders and Identification Test-Consumption) men ≥4, women ≥3.
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43.4, SF-12 MCS: 47.0), disease-specific HRQoL showed
that patients reported being most affected by limitations in
their daily life regarding “freedom to eat”, “sex life”, and
“freedom to drink”, while “people’s reaction” and “finan-
cial situation” mattered least (fig. 1). Mean patient assess-
ment of chronic illness care (PACIC) score was 2.8 (1 =
lowest to 5 = highest congruency).
Diabetes education, self-management support and self-
efficacy
Home glucose self-monitoring was frequently used
(81.6%) (fig. 2A), but HbA1c knowledge (58.3%) and parti-
cipation in a diabetes education course (32.8%) were rather
low. Only 14.3% were members of the local diabetes as-
sociation and 18.4% knew about the “Diabetes Passport”.
Measures of “self-efficacy” showed that diet posed a great-
Figure 1
Average weighted impact score of the 19 domains of the ADDQoL.
ADDQoL = Audit of Diabetes-Dependent Quality of Life
Figure 2
Self-management support. A. Knowledge and information. B. “Self-
efficacy” measures. C. Social support and satisfaction about it.
AVD = Association Vaudoise du Diabète; HbA1c = glycosylated
haemoglobin
er difficulty when compared with daily general diabetes
management (fig. 2B). In addition, the majority of patients
felt well- to very well-informed about their chronic disease
(85.9%), with the major provider of information being their
medical doctors (92%). Other sources of information were
media (30.8%), other healthcare professionals (23.5%), so-
cial network (8.6%), association or healthcare network
(5.7%), alternate sources (3.9%) and none (1.8%). Finally,
67% of the participants were well- or very-well satisfied
about their care, and nearly 58% would definitely recom-
mend the care received (fig. 2C). Most were satisfied by the
support obtained from their healthcare team (72.6%) and
members of their social network (72.3%).
Discussion
In this survey, we comprehensively described the care of
a cohort of 519 patients with diabetes in the canton of
Vaud, Switzerland. Our results signalled that quality gaps
remained, especially for certain diabetes-specific quality
indicators. We also noted a disconnection between patients’
perceptions and their actual disease knowledge and care;
indeed, patients felt satisfyingly informed about diabetes,
but yet many reported not even knowing what HbA1c
meant. Although satisfaction with and support from health-
care providers were rated high and the majority of par-
ticipants would recommend their healthcare, recommend-
ations about physical activity and diet were well below
goal. This is doubly significant as patients expressed their
greatest management difficulties in these areas.
The percentage of patients reporting uncontrolled diabetes
(5.7%), defined by a HbA1c over 9%, as well as the per-
centage of patients with HbA1c level below 8% (73%),
were below and above, respectively, the 15% and 60% cut-
off recommended by the Swiss society of endocrinology
and diabetology (E. Christ, personal communication). The
mean self-reported HbA1c value was good (7.3%), but only
available for the 177 HbA1c-aware patients. Mean HbA1c
levels for the whole sample would probably be less satis-
factory.
Generic HRQoL results showed that patients reported bet-
ter MCS than PCS scores; this is similar to previous
population-based studies on diabetes using the SF-12 scor-
ing [22, 23]. Diabetes-specific HRQoL measures
(ADDQoL) showed that “freedom to eat” was a quality-of-
life domain where patients felt particularly affected. This
difficulty, also reported by Collins et al. [24], echoed the
fact that patients reported more difficulties when it came
to the management not only of diet but also of physical
activity. These findings point to the need for more emphas-
is on guiding patients on these topics since patients repor-
ted few recommendations regarding both diet and physical
activity. Increased participation in diabetes education pro-
grammes and diabetes association could be a targeted way
to address these needs since higher levels of self-manage-
ment and self-efficacy have been shown to have a positive
impact on diabetes-related outcomes such as HbA1c [25].
Another way to improve patient’ knowledge, attitudes and
behaviour about nutrition could be to increase physicians’
referral to dieticians and specialised nurses. This would be
particularly appropriate since our participants reported un-
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satisfactory health behaviours (i.e., smoking, drinking and
physical activity status), and under-utilisation of such re-
sources was previously described in that population [26].
Even though both satisfaction and support from healthcare
providers were globally well ranked, and about 60% of
the patients would definitely recommend their healthcare,
few participants were informed about the canton’s diabetes
association, programme or activities that could help im-
prove their empowerment. This should be improved since
we know that patients who receive more support from their
Table 2: Patient-reported primary outcomes.
Processes-of-care indicators within the prior 12 months: Percentage 95% CI
HbA1c check among HbA1c aware patients (n = 282)
1x 14.7% 10.8%–19.8%
≥2x 83.6% 78.2%–87.9%
None 1.1% 0.4%–3.1%
Do not know 0.8% 0.2%–2.7%
Blood pressure measurement (n = 509)
1x 12.6% 9.8%–16.1%
2–3x 41.7% 37.2%–46.3%
≥4x 43.4% 39.0%–47.9%
None 1.8% 1.1%–3.1%
Do not know 0.9% 0.4%–2.1%
Weight measurement (n = 507)
Yes 93.4% 90.5%–95.4%
No 6.2% 4.3%–9.0%
Do not know 0.4% 0.1%–1.5%
Lipid profile (n = 513)
Yes 94.1% 91.8%–95.7%
No 3.2% 2.1%–5.1%
Do not know 2.4% 1.3%–4.3%
Diabetic foot examination by a physician (n = 510)
Yes 67.2% 62.1%–71.9%
No 31.8% 27.0%–37.0%
Do not know 0.8% 0.3%–2.5%
Urine test (for microalbuminuria) (n = 512)
Yes 64.5% 59.1%–69.6%
No 21.6% 18.0%–25.6%
Do not know 14.6% 11.3%–18.6%
Influenza vaccination (n = 514)
Yes 63.5% 59.8%–66.9%
No 36.4% 33.0%–40.0%
Do not know 0.2% 0.0%–1.4%
Eye assessment by ophthalmologist (n = 511)
<1 year 58.2% 53.8%–62.5%
1–2 years 17.9% 15.1%–21.1%
>2 years 12.5% 9.6%–16.1%
Never 9.5% 7.3%–12.3%
Do not know 1.5% 0.7%–3.3%
Physical activity recommendations, written or verbal* (n = 509)
Yes 67.9% 65.5%–70.2%
No 32.7% 31.2%–34.3%
Do not know 0.4% 0.1%–1.5%
Diet recommendations, written or verbal* (n = 510)
Yes 49.0% 44.2%–53.9%
No 50.6% 45.8%–55.4%
Do not know 0.4% 0.1%–1.5%
Outcomes of care: Mean 95% CI
HbA1c value among HbA1c -aware patients (%) (n = 177) 7.3 7.1–7.5
Health-related quality of life
SF-12 PCS (n = 498) 43.4 42.3–44.4
SF-12 MCS (n = 496) 47.0 46.0–48.0
ADDQoL global score (n = 512) –1.6 –1.7 – –1.4
PACIC global score (n = 503) 2.8 2.7–2.9
ADDQoL = Audit of Diabetes Dependent Quality of Life questionnaire; CI = confidence interval; MCS = Mental Component Score; PACIC = Patient Assessment of Chronic
Illness Care questionnaire; PCS = Physical Component Scor; SF-12 = Short Form-12.
* Without time frame
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social network or healthcare providers possess more self-
management skills and self-efficacy regarding their dia-
betes, and feel more confident about their ability to com-
plete health-promoting activities [27, 28]. Planning activ-
ities for patients with diabetes is important. All healthcare
providers should be involved in promoting these resources
to patients.
The collection of a broad range of outcomes and measures
is an added value of this study. However, some limitations
must be taken into consideration. First, these results are
based on patients’ self-report which may be prone to recall
bias. However, supplementary analyses demonstrated good
correlation between patient-reported data and physician re-
cords for simple processes-of-care, when data was supplied
by the treating physician for a fraction of the cohort (H.
Collet, personal communication); in addition, these results
were similar to those of other population-based studies
[29]. Also, despite the possibility of under- or over-estim-
ation of self-report indicators of care, patient-reported out-
comes are important measures to consider when evaluat-
ing the health status of a population and its needs regarding
healthcare [15]. Second, 519 patients were recruited in the
study instead of the 600 targeted. As we had more clusters
(pharmacies) than expected, and because of our conser-
vative sample size calculations, the precision around point
estimates was nevertheless acceptable. Finally, our results
may not be generalisable to the whole population of pa-
tients with diabetes in the canton of Vaud, as only patients
fluent enough in French to fill in a questionnaire, and with
a diagnosis of diabetes for over a year and visiting a phar-
macy, were recruited. We cannot exclude that results might
have been different with the inclusion of patients speaking
foreign languages such as migrants or highly-skilled and
educated English-speaking expatriate workers. However,
the direction and size of the effect of a broader inclusion
of patients may not be so straightforward to apprehend.
Also, participants showed similar characteristics in terms
of age, gender, education and BMI than those from prior
studies in the same canton [6, 30]. In addition, they rep-
resent a population-based sample of patients with diabetes
more closely than participants recruited in hospitals [9].
These findings will be useful for the further development
and evaluation of the “Programme cantonal Diabète”. They
are particularly interesting since they constitute the
baseline data of the cohort of patients with diabetes in
the canton of Vaud (CoDiab-VD). On a more global level,
these results shall support institutional strategies to close
knowledge gaps for patients with diabetes. More specific-
ally, they should ensure that all processes-of-care are re-
ceived by patients – especially those specific to diabetes
care, and that diabetes education programmes are promoted
and made accessible to all patients. A special emphasis
should be given to diet and physical activity education and
support. As this study covered a wide spectrum of qual-
ity of care indicators, these results should be of interest
to healthcare stakeholders seeking to improve care for pa-
tients with diabetes both in Switzerland and elsewhere.
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Figures (large format)
Figure 1
Average weighted impact score of the 19 domains of the ADDQoL.
ADDQoL = Audit of Diabetes-Dependent Quality of Life
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Figure 2
Self-management support. A. Knowledge and information. B. “Self-efficacy” measures. C. Social support and satisfaction about it.
AVD = Association Vaudoise du Diabète; HbA1c = glycosylated haemoglobin
Original article Swiss Med Wkly. 2014;144:w13951
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